Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7161–7180 of 17,529 recalls

June 18, 2019· Premier Pharmacy Labs Inc

Recalled Item: Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 18, 2019· Premier Pharmacy Labs Inc

Recalled Item: Phenylephrine HCL PF INJ in 0.9% Sodium Chloride

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 18, 2019· Premier Pharmacy Labs Inc

Recalled Item: Naloxone HCL Preserved INJ

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 17, 2019· Bausch & Lomb

Recalled Item: Lotemax (loteprednol etabonate ophthalmic gel 0.5%)

The Issue: Failed Stability Specifications: Out of specification for viscosity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
June 14, 2019· Golden State Medical Supply Inc.

Recalled Item: Losartan Potassium

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) dete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 14, 2019· Golden State Medical Supply Inc.

Recalled Item: Losartan Potassium

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) dete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 14, 2019· Golden State Medical Supply Inc.

Recalled Item: Losartan Potassium

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) dete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 14, 2019· Golden State Medical Supply Inc.

Recalled Item: Losartan Potassium

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) dete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 13, 2019· B. Braun Medical Inc

Recalled Item: Heparin Sodium 25

The Issue: Subpotent Drug: low out-of-specification results were identified for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 13, 2019· Baxter Healthcare Corporation

Recalled Item: Sevoflurane

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: REMICADE 680 MG QS 250 ML 0.9% NACL IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: METHOTREXATE 25 MG / 1 ML IM SYR

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: Sodium Chloride 0.9% 1 LITER WITH Potassium Chloride 20 mEq

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: DEXAMETHASONE 10 MG / 50 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: DACARBAZINE 680 MG in 250 ml NS

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: GRANISETRON 1000 MCG / 50 ML NS

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: VINCRISTINE 1 MG /50 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: Cytarabine 128 MG/250 ML D5W IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund